Patents by Inventor John A. Stringer

John A. Stringer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6602708
    Abstract: Production of fully differentiated, optionally immortalized, neural cells—by enhancing replication then inducing differentiation by mimicking cell's natural environment in vitro. The cells are useful for transplantation or drug screening.
    Type: Grant
    Filed: December 6, 1999
    Date of Patent: August 5, 2003
    Assignee: CellFactors plc
    Inventor: Bradley Michael John Stringer
  • Publication number: 20030110524
    Abstract: Transgenic organisms (in particular, transgenic animals or plants) bearing positive and/or negative selectable markers are described along with their use in various methods including tissue/cell culture techniques, methods of making monoclonal antibodies, methods of selectively eliminating or depleting a particular tissue/cell type, methods of screening compounds for pharmacological activity and methods of determining the effect of a deficit in a first class of cells or the characteristics of a second class of cells in an organism.
    Type: Application
    Filed: December 14, 1999
    Publication date: June 12, 2003
    Inventor: BRADLEY MICHAEL JOHN STRINGER
  • Patent number: 6558664
    Abstract: The invention relates to chondrocytes and chondrocyte cell-lines for use especially in studying arthritic conditions and also for developing skeletal tissue for use in repair and/or replacement surgery. The use of articular chondrocyte cell-lines which mineralize calcium to determine potentially beneficial therapeutic agents is disclosed. Further, the means for producing such cell-lines is also disclosed as well as the characteristics of such cell-lines. The use of hypertrophic chondrocyte cell-lines to produce matrix tissue is also disclosed. Further means of producing hypertrophic chondrocyte cell-lines is also disclosed as well as the charateristics of such cell-lines.
    Type: Grant
    Filed: September 16, 1999
    Date of Patent: May 6, 2003
    Assignee: Cell Factors plc
    Inventor: Bradley Michael John Stringer
  • Publication number: 20030064511
    Abstract: The invention relates to chondrocytes and chondrocyte cell-lines for use especially in studying arthritic conditions and also for developing skeletal tissue for use in repair and/or replacement surgery. The use of articular chondrocyte cell-lines which mineralize calcium to determine potentially beneficial therapeutic agents is disclosed. Further, the means for producing such cell-lines is also disclosed as well as the characteristics of such cell-lines. The use of hypertrophic chondrocyte cell-lines to produce matrix tissue is also disclosed. Further means of producing hypertrophic chondrocyte cell-lines is also disclosed as well as the charateristics of such cell-lines.
    Type: Application
    Filed: September 5, 2002
    Publication date: April 3, 2003
    Inventor: Bradley Michael John Stringer
  • Publication number: 20020094754
    Abstract: The invention relates to chondrocytes and chondrocyte cell-lines for use especially in studying arthritic conditions and also for developing skeletal tissue for use in repair and/or replacement surgery. The use of articular chondrocyte cell-lines which mineralise calcium to determine potentially beneficial therapeutic agents is disclosed. Further, the means for producing such cell-lines is also disclosed as well as the characteristics of such cell-lines. The use of hypertrophic chondrocyte cell-lines to produce matrix tissue is also disclosed. Further means of producing hypertrophic chondrocyte cell-lines is also disclosed as well as the charateristics of such cell-lines.
    Type: Application
    Filed: November 14, 2001
    Publication date: July 18, 2002
    Inventor: Bradley Michael John Stringer
  • Patent number: 6380742
    Abstract: An NMR probe, lacking electrical balance in respect of the RF coil thereof, includes a conducting shield of axial extent greater than &lgr;/4 from the ground plane closure of said shield of the probe (&lgr; being the highest resonant frequency of interest), the components of the probe other than the coil being confined to the axial region less than &lgr;/4 from the ground plane and spaced apart from the shield.
    Type: Grant
    Filed: July 27, 2001
    Date of Patent: April 30, 2002
    Assignee: Varian, Inc.
    Inventors: John Stringer, Charles E. Bronnimann
  • Patent number: 6340592
    Abstract: The invention relates to a method for producing human cell lines and cell and cell-lines produced by such a method. The method comprising the use of precursor or undifferentiated cells treated with an immortalising agent which is susceptible to environmental conditions so as to provide for selective activation/deactivation of said immortalising agent and so selective activation of differentiation.
    Type: Grant
    Filed: October 23, 2000
    Date of Patent: January 22, 2002
    Assignee: CellFactors plc
    Inventor: Bradley Michael John Stringer
  • Publication number: 20010049143
    Abstract: A method for producing human cell lines by immortalizing a precursor or undifferentiated cell with a controllable immortalizing agent, culturing the cell to provide a cell population, and terminating immobilization to allow differentiation.
    Type: Application
    Filed: April 18, 2001
    Publication date: December 6, 2001
    Inventor: Bradley Michael John Stringer
  • Patent number: 6197585
    Abstract: The invention relates to a method for producing human cell lines and cell and cell-lines produced by such a method. The method comprising the use of precursor or undifferentiated cells treated with an immortalising agent which is susceptible to environmental conditions so as to provide for selective activation/deactivation of said immortalising agent and so selective activation of differentiation.
    Type: Grant
    Filed: September 3, 1999
    Date of Patent: March 6, 2001
    Assignee: CellFactors plc
    Inventor: Bradley Michael John Stringer
  • Patent number: 4057729
    Abstract: Consistencies of aqueous slurries, such as cellulose slurries, are measured by immersing in the slurry a radioactive source of fast neutrons, and neutron detector at a fixed, predetermined distance from the source. The neutron count so obtained can be used to determine slurry consistency. If a second neutron detector is immersed in the slurry at a predetermined, greater distance from the neutron source, the two neutron counts can be used to determine both the slurry consistency and the density of the suspended material.
    Type: Grant
    Filed: February 6, 1976
    Date of Patent: November 8, 1977
    Inventor: John Stringer Hewitt